58 related articles for article (PubMed ID: 34019866)
1. Identification of novel ALK fusions using DNA/RNA sequencing in immunohistochemistry / RT-PCR discordant NSCLC patients.
Wang B; Chen R; Wang C; Guo J; Yuan M; Chen H; Xia X; Zhong D
Hum Pathol; 2021 Aug; 114():90-98. PubMed ID: 34019866
[TBL] [Abstract][Full Text] [Related]
2. Concordance of ALK fusion gene-rearrangement between immunohistochemistry and next-generation sequencing.
Wakuda K; Morita M; Sekikawa M; Morikawa N; Miura K; Doshita K; Iida Y; Kodama H; Mamesaya N; Kobayashi H; Ko R; Ono A; Kenmotsu H; Naito T; Murakami H; Muramatsu K; Kawata T; Mori K; Shimizu T; Gon Y; Takahashi T
Int J Clin Oncol; 2024 Feb; 29(2):96-102. PubMed ID: 38183554
[TBL] [Abstract][Full Text] [Related]
3. Multicenter evaluation of an automated, multiplex, RNA-based molecular assay for detection of ALK, ROS1, RET fusions and MET exon 14 skipping in NSCLC.
Melchior L; Hirschmann A; Hofman P; Bontoux C; Concha A; Mrabet-Dahbi S; Vannuffel P; Watkin E; Putzová M; Scarpino S; Cayre A; Martin P; Stoehr R; Hartmann A
Virchows Arch; 2024 Apr; 484(4):677-686. PubMed ID: 38492039
[TBL] [Abstract][Full Text] [Related]
4.
Su C; Jiang Y; Jiang W; Wang H; Liu S; Shao Y; Zhao W; Ning R; Yu Q
Onco Targets Ther; 2020; 13():12515-12519. PubMed ID: 33311990
[TBL] [Abstract][Full Text] [Related]
5. Molecular Screening in Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma: Anaplastic Lymphoma Kinase Analysis, Next-Generation Sequencing Fusion Gene Detection, and T-Cell Receptor Immunoprofiling.
Kalinova M; Mrhalova M; Kabickova E; Svaton M; Skotnicova A; Prouzova Z; Krenova Z; Kolenova A; Divoka M; Fronkova E; Kodet R
Mod Pathol; 2024 Mar; 37(3):100428. PubMed ID: 38266918
[TBL] [Abstract][Full Text] [Related]
6. Catalog of 5' Fusion Partners in
Ou SI; Zhu VW; Nagasaka M
JTO Clin Res Rep; 2020 Mar; 1(1):100015. PubMed ID: 34589917
[TBL] [Abstract][Full Text] [Related]
7. Detection of an
Lai AZ; Schrock AB; Erlich RL; Ross JS; Miller VA; Yakirevich E; Ali SM; Braiteh F
Oncologist; 2017 Jul; 22(7):774-779. PubMed ID: 28507204
[TBL] [Abstract][Full Text] [Related]
8.
Conde E; Hernandez S; Rodriguez Carrillo JL; Martinez R; Alonso M; Curto D; Jimenez B; Caminoa A; Benito A; Garrido P; Clave S; Arriola E; Esteban-Rodriguez I; De Castro J; Sansano I; Felip E; Rojo F; Dómine M; Abdulkader I; Garcia-Gonzalez J; Teixido C; Reguart N; Compañ D; Insa A; Mancheño N; Palanca S; Juan-Vidal O; Baixeras N; Nadal E; Cebollero M; Calles A; Martin P; Salas C; Provencio M; Aranda I; Massuti B; Lopez-Vilaro L; Majem M; Paz-Ares L; Lopez-Rios F
JTO Clin Res Rep; 2024 Apr; 5(4):100653. PubMed ID: 38525319
[TBL] [Abstract][Full Text] [Related]
9. RT-PCR assay to detect
Priesterbach-Ackley LP; van Kuik J; Tops BBJ; Lasorella A; Iavarone A; van Hecke W; Robe PA; Wesseling P; de Leng WWJ
Neurooncol Pract; 2024 Apr; 11(2):142-149. PubMed ID: 38496910
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive assessment of anaplastic lymphoma kinase in localized and metastatic prostate cancer reveals targetable alterations.
Patel RA; Coleman I; Roudier MP; Konnick EQ; Hanratty B; Dumpit R; Lucas JM; Ang LS; Low JY; Tretiakova MS; Ha G; Lee JK; True LD; De Marzo AM; Nelson PS; Morrissey C; Pritchard CC; Haffner MC
Cancer Res Commun; 2022 May; 2(5):277-285. PubMed ID: 36337169
[TBL] [Abstract][Full Text] [Related]
11. A Molecular Blueprint to Targeting ALK Gene Fusions in Glioblastoma.
Mack SC; Bertrand KC
Clin Cancer Res; 2023 Jul; 29(14):2567-2569. PubMed ID: 37260294
[TBL] [Abstract][Full Text] [Related]
12. Design, Optimization, and Multisite Evaluation of a Targeted Next-Generation Sequencing Assay System for Chimeric RNAs from Gene Fusions and Exon-Skipping Events in Non-Small Cell Lung Cancer.
Blidner RA; Haynes BC; Hyter S; Schmitt S; Pessetto ZY; Godwin AK; Su D; Hurban P; van Kempen LC; Aguirre ML; Gokul S; Cardwell RD; Latham GJ
J Mol Diagn; 2019 Mar; 21(2):352-365. PubMed ID: 30529127
[TBL] [Abstract][Full Text] [Related]
13. A Highly Sensitive XNA-Based RT-qPCR Assay for the Identification of ALK, RET, and ROS1 Fusions in Lung Cancer.
Lee B; Chern A; Fu AY; Zhang A; Sha MY
Diagnostics (Basel); 2024 Feb; 14(5):. PubMed ID: 38472960
[TBL] [Abstract][Full Text] [Related]
14. FindDNAFusion: An Analytical Pipeline with Multiple Software Tools Improves Detection of Cancer-Associated Gene Fusions from Genomic DNA.
Pan X; Tu H; Mohamed N; Avenarius M; Caruthers S; Zhao W; Jones D
J Mol Diagn; 2024 Feb; 26(2):140-149. PubMed ID: 38008285
[TBL] [Abstract][Full Text] [Related]
15. Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain Tumors.
Galbraith K; Serrano J; Shen G; Tran I; Slocum CC; Ketchum C; Abdullaev Z; Turakulov R; Bale T; Ladanyi M; Sukhadia P; Zaidinski M; Mullaney K; DiNapoli S; Liechty BL; Barbaro M; Allen JC; Gardner SL; Wisoff J; Harter D; Hidalgo ET; Golfinos JG; Orringer DA; Aldape K; Benhamida J; Wrzeszczynski KO; Jour G; Snuderl M
Mol Cancer Res; 2024 Jan; 22(1):21-28. PubMed ID: 37870438
[TBL] [Abstract][Full Text] [Related]
16. Fusion of old and new: Employing touch imprint slides for next generation sequencing in solid tumors.
Aydin Mericoz C; Eren OC; Kulac I; Firat P
Diagn Cytopathol; 2024 May; 52(5):264-270. PubMed ID: 38339821
[TBL] [Abstract][Full Text] [Related]
17. Circulating Tumor DNA Enables Sensitive Detection of Actionable Gene Fusions and Rearrangements Across Cancer Types.
Kasi PM; Lee JK; Pasquina LW; Decker B; Vanden Borre P; Pavlick DC; Allen JM; Parachoniak C; Quintanilha JCF; Graf RP; Schrock AB; Oxnard GR; Lovly CM; Tukachinsky H; Subbiah V
Clin Cancer Res; 2024 Feb; 30(4):836-848. PubMed ID: 38060240
[TBL] [Abstract][Full Text] [Related]
18. Detection of NRG1 Gene Fusions in Solid Tumors.
Jonna S; Feldman RA; Swensen J; Gatalica Z; Korn WM; Borghaei H; Ma PC; Nieva JJ; Spira AI; Vanderwalde AM; Wozniak AJ; Kim ES; Liu SV
Clin Cancer Res; 2019 Aug; 25(16):4966-4972. PubMed ID: 30988082
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic impact of RNA-based next-generation sequencing fusion panel for solid tumors: A single-institution experience.
Fei F; Kunder CA; Ho C; Zehnder JL; Tomasello G; Fung E; Suarez CJ
Am J Clin Pathol; 2024 Apr; 161(4):329-341. PubMed ID: 38001052
[TBL] [Abstract][Full Text] [Related]
20. FACTERA: a practical method for the discovery of genomic rearrangements at breakpoint resolution.
Newman AM; Bratman SV; Stehr H; Lee LJ; Liu CL; Diehn M; Alizadeh AA
Bioinformatics; 2014 Dec; 30(23):3390-3. PubMed ID: 25143292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
